Upload File

pathogenesis of asthma and omalizumab action

9
Pathogenesi s of asthma

Upload: muhammad-ali

Post on 31-May-2015

161 views

Category:

Documents


2 download

Report

TRANSCRIPT

Page 1: Pathogenesis of asthma and omalizumab action

Pathogenesis of asthma

Page 2: Pathogenesis of asthma and omalizumab action

EPI

GC

DC

antigens

GC

DCDC

Th-2 Activatio

n

Cytokines release

IL-4IL-5IL-13

Air Way

Interstitium

Pathogenesis of Br Asthma

Th2

Page 3: Pathogenesis of asthma and omalizumab action

IL-4IL-5IL-13

IL-4IL-13

B Cell

Plasma cells

IgE release

Mast Cell

Bas-phil

Causes eosinophili

a IL-13 also causes:

Inc. mucus

secretion

Hyperresponsivene

ss

Activation &

Converted to

Page 4: Pathogenesis of asthma and omalizumab action

Cytokines release

IL-4

B Cell

Plasma cells

IgE release

Mast Cell

Bas-phil

Page 5: Pathogenesis of asthma and omalizumab action

Mast Cell

Bas-phil

Free Ig E

FcεRI receptor

Cε3 domain

Bound Ig E

Mechanism of action of Omalizumab

Omalizumab binds to free IgE with

Cε3 domain

Page 6: Pathogenesis of asthma and omalizumab action

Mast Cell

Bas-phil

FcεRI receptor

Bound Ig E

Mechanism of action of Omalizumab

Page 7: Pathogenesis of asthma and omalizumab action
Page 8: Pathogenesis of asthma and omalizumab action
Page 9: Pathogenesis of asthma and omalizumab action

Urticaria crónica y tratamiento con omalizumab

Xolair® (Omalizumab)

(Research Use Only) - Eagle Biosciences · Catalog Number: R111 Instructions BioTeZ recoveryELISA Omalizumab IgE ELISA Assay Kit (RIO) Introduction Allergic asthma is a widespread

Macrophage dysfunction in the pathogenesis and treatment of … · Macrophage dysfunction in the pathogenesis and treatment of asthma Michael Fricker1 and Peter G. Gibson1,2 Affiliations:

FDA Advisory Committee May 15, 2003 Genentech Marketing Application STN 103976 / 0 Omalizumab Recombinant human anti-IgE for treatment of asthma Efficacy

HEPATIT C OLGULARINDA CALISMA PLANI€¦ · 10. Yalcin AD, Strauss LG, Gumuslu S,Cilli A, Hert F. Omalizumab is effective in treating severe asthma in patients with severe cadiovascular

microarray analysis identifies arginase in Dissection of ......Dissection of experimental asthma with DNA microarray analysis identifies arginase in asthma pathogenesis Nives Zimmermann,

Occupational asthma: Pathogenesis - UFPR...eosinophilic bronchitis) [1]. Occupational asthma is a disease characterized by variable airflow limitation, airway hyperresponsiveness,

SECTION 2, DEFINITION, PATHOPHYSIOLOGY AND … 2, Definition, Pathophysiology and Pathogenesis of Asthma, and Natural History of Asthma 11 August 28, 2007 SECTION 2, DEFINITION, PATHOPHYSIOLOGY

PATHOGENESIS OF BRONCHIAL OBSTRUCTION - ASTHMA, COPD Zuzana Humlová Department of Pathophysiology 1st Medical Faculty of Charles University

Estudos Omalizumabe. EXCELs study Eisner MD et al, J Asthma 2012 Longitudinal Changes in Asthma Control with Omalizumab: 2-Year Interim Data from the

Drug Monograph: Omalizumab (XOLAIR

Australian public assessment report for Omalizumab

Experiencia omalizumab en pediatria

Journal review omalizumab

Omalizumab for previously treated chronic spontaneous

Asthma Sagal Yusuf #1447. General Outliune Introduction Definition Types of Asthma Epidemology Pathogenesis

38392 omalizumab

The real world effect of omalizumab add on therapy for ... · mab in the treatment of patients with moderate-to-severe allergic asthma (the ASTERIX Observational study). The primary

D-DIMER LEVELS decreased in severe allergic asthma and chronic urticaria patients with the omalizumab treatment

Pathogenesis of asthma

Farmacotherapeutisch rapport omalizumab (Xolair®)

Inhaler technique for people with asthma or COPD · severe asthma being considered for specialised medicines such as omalizumab, inhaler technique must be checked and documented

The Other T Helper Cells in Asthma Pathogenesis

Asthma Pathogenesis

New Therapies in Asthma - ACCP · PDF fileNew Therapies in Asthma ... Fukuda T. Prostaglandin D2 and Th2 inflammation in the pathogenesis of bronchial asthma. Korean J Int Med 2011;26:8-18;

Asthma SS Visser, Lung Unit, UP. Contents Definition Disease Pattern Prevalence Mortality Etiology Pathogenesis Triggers of acute attacks

Asthma - MHS Indiana · proinflammatory cascade in allergic asthma Omalizumab (Xolair)-only FDA approved anti-IgE therapy •Binds to human IgE's high affinity Fc receptor o Prevents

Bronchial asthma: the nature of the disease, pathogenesis ... · Bronchial asthma: the nature of the disease, pathogenesis, risk factors, epidemiology, and diagnosis Alan Altraja

Omalizumab in Severe Refractory Vernal Keratoconjunctivitis in … · 2017. 4. 11. · treatment of severe asthma. Few case reports suggest its efficacy in VKC and atopic keratoconjunctivitis

Definition, Pathophysiology, and Pathogenesis of · PDF fileSection 2, Definition, Pathophysiology and Pathogenesis of Asthma, ... Airway inflammation contributes to airway hyperresponsiveness,

Xolair® (omalizumab) (last updated 10/2019) · 10/1/2019  · 2. National Asthma Education and Prevention Program (NAEPP). Guidelines for the diagnosis and management of asthma

Imbalance of gdT17/gdTreg cells in the pathogenesis of ...Emerging evidence has suggested that gdT cells, a T cell subset, have a critical role in the pathogenesis of asthma, such

These anti IgE omalizumab

Asma, IgE y omalizumab